Skip to content

Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and Biodegradable Spacer.

Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and or Biodegradable Spacer: a Prospective Randomized Clinical Trial.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04571918
Acronym
AMRIS
Enrollment
50
Registered
2020-10-01
Start date
2020-11-01
Completion date
2029-09-01
Last updated
2020-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Massive Rotator Cuff Tears

Keywords

Ballon spacer, Biodegradable spacer, Subacromial spacer

Brief summary

Massive rotator cuff tears are common in the adult population. It is estimated that about 12 % of adults 60 years of age or older suffer from a rotator cuff injury. About 40 % of these injuries are classified as massive rotator cuff tears (MRCT). MRCT propose a great challenge to the affected patient and its doctor. It is a painful condition with few treatment options. The study aims to investigate the operative treatment for MRCT with the new treatment option proposed by Senecovic. Insertion of a biodegradable balloon as a subacromial spacer has proven promising results so far. To this date there is only small and non-randomized studies on the subject. AMRIS are planning to do a randomized controlled study where group A is treated with arthroscopic debridement, biceps tenotomy and biodegradable spacer, while group B, the control group are treated with arthroscopic debridement and biceps tenotomy.

Detailed description

The study is designed as a double blinded randomized controlled trial. The physiotherapist responsible for the clinical testing and the patient are both blinded. The surgeon knows which group the patient is in but is not responsible for any of the testing. We will randomize with envelopes perioperatively. The participants are randomized in hence ballon or not ballon. In advance of the randomization the surgeon will evaluate if the patient is candidate for partial suture before randomization. We plan to stratify the patients with partial suture to ensure homogeneity between the groups. The operation will start with arthroscopic debridement and biceps tenotomy in both groups. The patients are thereby evaluated for partial suture and randomized. The insertion of the subacromial spacer is done at the end of the operation for those patients randomized to the group balloon. Peroperatively the surgeon will classify the grade of osteoarthritis with Outerbridge classification and the state of the rotator cuff and the long head of the biceps tendon. Postoperative mobilization will be the following: * 0-2 weeks: Immobilization in a sling. The participant is advised to do simple exercises for shoulder mobilization. Restriction of movement above shoulder level. * 2-6 weeks: Free mobilization. Advised to avoid heavy lifting. * 6-12 weeks: Work on increasing range of motion, gradually introduce weight lifting.

Interventions

PROCEDUREBiodegradable spacer

Implantation of a biodegradable balloon used as a subacromial spacer.

PROCEDUREDebridement and biceps tenotomy

Surgery with arthroscopic debridement and biceps tenotomy

Sponsors

Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Both participant and physiotherapist who are responsible for the testing will be masked.

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients suffering from a symptomatic massive rotator cuff tear, with fatty infiltration grade 3 or 4 classified on CT by Goutallier et al, or MRI by Fuchs classification. * Persistent pain for at least 3 months, with documented failure of conservative treatment * Age ranging from 60 years of age to 85 years of age

Exclusion criteria

* Significant shoulder osteoarthritis in the affected shoulder, Hamada classification \>2. * Total rupture of subscapularis tendon and/or teres minor, classified B and E in the Collins classification. * Comorbidity to the degree that the patient will not be able to participate in the follow up program.

Design outcomes

Primary

MeasureTime frameDescription
Change in Constant scorePreop, 6 months, 1 year, 2 years, 5 years, 10 years.A well review score that takes several factors in to account: active range of motion, activities of daily living, pain and strength. A person with a normal, healthy shoulder should score 100 points, which is maximum score. Constant score is seen as a relatively objective test, as the testing will be performed by a physiotherapist.

Secondary

MeasureTime frameDescription
WORCPreop. Postop: 3 months, 6 months, 1 year, 2 years, 5 years, 10 yearsWestern Ontario Rotator Cuff Index is a questionnaire that explores 5 domains: physical symptoms, sports and recreation, work, social function, emotions.
X-ray of the shoulderPreop. Postop: 1. day, 1 year, 2 years, 5 years, 10 yearsMeasure the height from the head of the humerus to the acromion
VASPreop. Postop: 3 months, 6 months, 1 year, 2 years, 5 years, 10 yearsVisual analog scale for pain in rest, activity and at night. Scale from 0 til 10.
Eq-5DPreop. Postop: 3 months, 6 months, 1 year, 2 years, 5 years, 10 yearsQuestionaire for daily activity

Countries

Norway

Contacts

Primary ContactHannah Ugletveit Jahr, Cand. med.
hannah.jahr@gmail.com+47 90762377
Backup ContactBerte Bøe, PhD
uxbebm@ous-hf.no+47 41338451

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026